Search peptides, terms, sources/
Research source · 2010

A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers

About this source

Kind
Research
Design
RCT, Human clinical trial
Population
Human healthy adults, 40 volunteers in four cohorts of 10, Phase 1
Sample size
40
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Phase 1 safety and pharmacokinetic study in healthy people. Intravenous route, a different route from the eye drops and topical products in the efficacy trials. Verified from the Europe PMC abstract record.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.